Topic
generic drugs
Trump's Generic Drug Tariffs Explained: What It Means for Indian Pharma Before the 200% Storm
US President Donald Trump unveiled a phased tariff plan for imported generic medicines: duty-free for two years from August 1, then 100% for one year, followed by 200%. For Indian drugmakers, the plan offers temporary relief but signals a long-term shift. India's pharma exports to the US account for 34% of total pharma exports, worth $30.47 billion in 2024-25. Leading companies with US manufacturing operations may have greater flexibility.
Trump's Phased Tariff Plan on Generic Drugs: 0% for Two Years, Then Up to 200%
President Donald Trump announced a phased tariff plan on imported generic medicines, with zero tariffs for two years from August 1, 2026, followed by 100% for one year and 200% thereafter. The move targets India, which exported $9.7 billion in pharmaceuticals to the US in 2025, accounting for 38% of its total pharma exports. Indian generics supply 47% of US prescriptions and saved the US healthcare system $219 billion in 2022.